AAAAAA
Results:
1-14
|
Results: 14
Authors:
Wierzbicki, AS
Watts, GF
Lynas, J
Winder, AF
Wray, R
Citation: As. Wierzbicki et al., Very low-density lipoprotein apolipoprotein B-100 turnover in glycogen storage disease type Ia (von Gierke disease), J INH MET D, 24(5), 2001, pp. 527-534
Authors:
Winder, AF
Citation: Af. Winder, On the diagnosis of heterozygous familial hypercholesterolaemia HFH, INT J CARD, 74(1), 2000, pp. 13-14
Authors:
Milionis, HJ
Winder, AF
Mikhailidis, DP
Citation: Hj. Milionis et al., Lipoprotein (a) and stroke, J CLIN PATH, 53(7), 2000, pp. 487-496
Authors:
Wierzbicki, AS
Crook, MA
Nair, DR
Mikhailidis, DP
Winder, AF
Citation: As. Wierzbicki et al., More on the effect of atorvastatin on plasma fibrinogen levels in primary hypercholesterolaemia, ATHEROSCLER, 148(1), 2000, pp. 204-204
Authors:
Wierzbicki, AS
Crook, MA
Mikhailidis, DP
Winder, AF
Citation: As. Wierzbicki et al., Natural statins and stroke, CIRCULATION, 101(3), 2000, pp. E45-E45
Authors:
Krijgsman, B
Mikhailides, DP
Winder, AF
Hamilton, G
Citation: B. Krijgsman et al., Bilirubin and peripheral vascular disease, BR J SURG, 87(2), 2000, pp. 251-252
Authors:
Milionis, HJ
Mikhailidis, DP
Winder, AF
Citation: Hj. Milionis et al., Platelets and lipoprotein (a): a brief overview of their role in the pathogenesis of atherothrombosis, PLATELETS, 10(5), 1999, pp. 277-284
Authors:
Papadakis, JA
Ganotakis, ES
Jagroop, IA
Mikhailidis, DP
Winder, AF
Citation: Ja. Papadakis et al., Effect of hypertension and its treatment on lipid, lipoprotein(a), fibrinogen, and bilirubin levels in patients referred for dyslipidemia, AM J HYPERT, 12(7), 1999, pp. 673-681
Authors:
Papadakis, JA
Ganotakis, ES
Jagroop, IA
Winder, AF
Mikhailidis, DP
Citation: Ja. Papadakis et al., Statin plus fibrate combination therapy - Fluvastatin with bezafibrate or ciprofibrate in high risk patients with vascular disease, INT J CARD, 69(3), 1999, pp. 237-244
Authors:
Lister, RK
Youle, M
Nair, DR
Winder, AF
Rustin, MHA
Citation: Rk. Lister et al., Latent dysbetalipoproteinaemia precipitated by HIV-protease inhibitors, LANCET, 353(9165), 1999, pp. 1678-1678
Authors:
Winder, AF
Owen, JS
Pritchard, PH
Lloyd-Jones, D
Vallance, DT
White, P
Wray, R
Citation: Af. Winder et al., A first British case of fish-eye disease presenting at age 75 years: a double heterozygote for defined and new mutations affecting LCAT structure andexpression, J CLIN PATH, 52(3), 1999, pp. 228-230
Authors:
Byrne, DJ
Neil, HAW
Vallance, DT
Winder, AF
Citation: Dj. Byrne et al., A pilot study of garlic consumption shows no significant effect on markersof oxidation or sub-fraction composition of low-density lipoprotein including lipoprotein(a) after allowance for non-compliance and the placebo effect, CLIN CHIM A, 285(1-2), 1999, pp. 21-33
Authors:
Mikhailidis, DP
Ganotakis, ES
Spyropoulos, KA
Jagroop, IA
Byrne, DJ
Winder, AF
Citation: Dp. Mikhailidis et al., Prothrombotic and lipoprotein variables in patients attending a cardiovascular risk management clinic: response to ciprofibrate or lifestyle advice, INT ANGIOL, 17(4), 1998, pp. 225-233
Authors:
Winder, AF
Jolleys, CW
Day, LB
Butowski, PF
Citation: Af. Winder et al., Corneal arcus, case finding and definition of individual clinical risk in heterozygous familial hypercholesterolaemia, CLIN GENET, 54(6), 1998, pp. 497-502
Risultati:
1-14
|